Splenic and lung response to nonlethal systemic Aspergillus fumigatus infection in C57BL/6 mice

References

• Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310–350.
   PubMed Web of Science ®Google Scholar
• Mullins J, Hutcheson PS, Slavin RG. Aspergillus fumigatus spore concentration in outside air: Cardiff and St. Luis compared. Clin Allergy 1984; 14: 351–354.
   PubMedGoogle Scholar
• Nolard N. Les liens entre les risques d’aspergilose et la contamination de l’environnement. Revue de la litterature. Pathol Biol 1994; 42: 706–710.
   Google Scholar
• Goodley JM, Clayton YM, Hay RJ. Environmental sampling for aspergilli during building construction on a hospital site. J Hosp Infect 1994; 26: 27–35.
   PubMed Web of Science ®Google Scholar
• Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentrations of air-borne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol 1998; 36: 165–168.
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1–23.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Stevens DA. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 2005; 43: S101–S110.
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, d'Ostiani CF, . Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998;178:1750–1760.
   PubMed Web of Science ®Google Scholar
• Centeno-Lima S, Silveira H, Casimiro C, Aguiar P, do Rosario VE. Kinetics of cytokine expression in mice with invasive aspergillosis: lethal infection and protection. FEMS Immunol Med Microbiol 2002;32:167–173.
   Google Scholar
• Schmidt A. Animal models of aspergillosis – also useful for vaccination strategies? Mycoses 2002; 45: 38–40.
   PubMed Web of Science ®Google Scholar
• Polak A. Experimental models in antifungal chemotherapy. Mycoses 1998;41:1–30.
   PubMed Web of Science ®Google Scholar
• Mirkov I, Zolotarevski L, Glamoclija J, Kataranovski D, Kataranovski M. Experimental disseminated aspergillosis in mice: histopathological study. J Med Mycol 2008;18:75–82.
   Web of Science ®Google Scholar
• Cenci E, Perito S, Enssle KH, . Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997;65:564–570.
   PubMed Web of Science ®Google Scholar
• Nagai H, Guo J, Choi HY, Kurup V. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J Infect Dis 1995; 172: 1554–1560.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Grunig G, Sobel RA, . Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000;122:186–191.
   PubMed Web of Science ®Google Scholar
• Palm NW, Medzhitov R. Antifungal defense turns 17. Nat Immunol 2007;8:549–551.
   Google Scholar
• Zelante T, De Luca A, D’Angelo C, Moretti S, Romani L. IL-17/ Th17 in anti-fungal immunity: what's new? Eur J Immunol 2009; 39:645–648.
   PubMed Web of Science ®Google Scholar
• Zelante T, De Luca A, Bonifazi P, . IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007;37:2695–2706.
   PubMed Web of Science ®Google Scholar
• Zelante T, Bozza S, De Luca A, . Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol 2009; 47: S162–S169.
   PubMed Web of Science ®Google Scholar
• Booth C. Fungal culture media. Norris JR, Ribbons DW. Methods in Microbiology, 4th edn. London & New York: Academic Press, 1971: 49–94.
   Google Scholar
• Sheppard DC, Marr KA, Fredricks DN, . Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin Microbiol Infect 2006;12:376–380.
   PubMed Web of Science ®Google Scholar
• Monboisse JC, Garnotel R, Randoux A, Dufer J, Borel JP. Adhesion of human neutrophils to and activation by type-I collagen involving a β2 integrin. J Leukoc Biol 1991;50:373–380.
   PubMed Web of Science ®Google Scholar
• Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005;5:606–616.
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family of cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821–852.
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Muller U, Brodie S, . IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006;176:1098–1106.
   PubMed Web of Science ®Google Scholar
• Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of inter-leukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004;190:624–631.
   PubMed Web of Science ®Google Scholar
• Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007;51:1139–1147.
   PubMed Web of Science ®Google Scholar
• Nakae S, Komiyama Y, Nambu A, . Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002;17:375–387.
   PubMed Web of Science ®Google Scholar
• Abbas AK, Lichtman AH, Pillai S. Cytokines. Schmitt W, Gruliow R. Cellular and Molecular Immunology, 6th edn. Philadelphia: Saunders Elsevier, 2007: 267–303.
   Google Scholar
• Bernhisel-Broadbent J, Camargo EE, Jaffe HS, Lederman HM. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J Infect Dis 1991;163:908–911.
   PubMed Web of Science ®Google Scholar
• Rex JH, Bennett JE, Gallin JI, . In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis 1991;163:849–852.
   PubMed Web of Science ®Google Scholar
• Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and γ-interferon. Infect Immun 1993;61:1185–1193.
   PubMed Web of Science ®Google Scholar
• de Repentigny L, Petitbois S, Boushira M, . Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect Immun 1993;61:3791–3802.
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Del Sero G, . Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 1999;180:1957–1968.
   PubMed Web of Science ®Google Scholar
• Rivera A, Van Epps HL, Hohl TM, Rizzuto G, Pamer EG. Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect Immun 2005;73:7170–7179.
   PubMed Web of Science ®Google Scholar
• Brieland JK, Jackson C, Menzel F, . Cytokine networking in lungs of immunocompetent mice in response to inhaled. Aspergillus fumigatus. Infect Immun 2001;69:1554–1560.
   PubMed Web of Science ®Google Scholar